CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma

Article Abstract:

The frequency and distribution of CD1d-restricted invariant natural killer T cells in the lungs and peripheral blood of patients with persistent asthma are studied to determine the role of invariant natural killer T cells in human asthma. The results suggest that invariant natural killer T cells in asthma represent a new model in which CD4+ natural killer T cells, along with conventional CD4+ T cells, produce interleukin-4 and interleukin-13, driving the development of inflammation in bronchial asthma.

England, Health aspects, Causes of, CD4 lymphocytes

---

Dysfunctional interaction of C/EBP and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells

Article Abstract:

The data indicate that the proliferation of airway smooth-muscle cells in patients with asthma may result from an absence of C/EBPalpha. Lines of bronchial smooth-muscle cells were established from cells from 20 subjects with asthma. The antiproliferative and the cytokine-inhibitory effects of glucocorticoids are mediated by different signaling pathways are demonstrated.

Care and treatment, Muscle cells, Cell proliferation

---

Similar abstracts:

• Abstracts: The need for natural killer T cells. Vitamin A helps gut T cells find their way in the dark
• Abstracts: No pancreatic endocrine stem cells?. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
• Abstracts: Airline travel and infection. The evolving technology of venous access. The antibiotic pipeline - challenges, costs, and values

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.